Increase of CD45-positive Immune Cells in Liver Parenchyma Indicates a More Favorable Prognosis for Patients With Barrett's Cancer.

Kemper, Marius; Strohm, Timo; Grupp, Katharina; Ghadban, Tarik; Bogoevski, Dean; Bachmann, Kai; Bockhorn, Maximilian; Sauter, Guido; Izbicki, Jakob R; Reeh, Matthias

Kemper, Marius; Strohm, Timo; Grupp, Katharina; Ghadban, Tarik; Bogoevski, Dean; Bachmann, Kai; Bockhorn, Maximilian; Sauter, Guido; Izbicki, Jakob R; Reeh, Matthias.

Afiliação

Kemper M; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Strohm T; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Grupp K; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Ghadban T; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Bogoevski D; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Bachmann K; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Bockhorn M; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Sauter G; Institute of Pathology, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Izbicki JR; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.
Reeh M; Department of General, Visceral and Thoracic Surgery, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany mreeh@uke.de.

Anticancer Res ; 39(3): 1191-1196, 2019 Mar.

Article em En | MEDLINE | ID: mdl-30842149

Assuntos

Adenocarcinoma/imunologia; Neoplasias Esofágicas/imunologia; Antígenos Comuns de Leucócito/imunologia; Neoplasias Hepáticas/imunologia; Adenocarcinoma/patologia; Neoplasias Esofágicas/patologia; Feminino; Humanos; Fígado/imunologia; Fígado/patologia; Neoplasias Hepáticas/secundário; Masculino; Pessoa de Meia-Idade; Prognóstico; Modelos de Riscos Proporcionais

Palavras-chave

Barret's cancer; CD45; Esophageal adenocarcinoma; PTPRC; TMA; immune checkpoint inhibition; personalized therapy; survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Adenocarcinoma / Antígenos Comuns de Leucócito / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google